Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 6, 2008, Pages 539-543

  Lima, E M ^a,f   Leal, M F ^b   Burbano, Rommel R ^c   Khayat, A S ^c   Assumpcao P P ^d   Bello, M J ^e   Rey, J A ^e   Smith, M A C ^b   Casartelli, C ^f  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d Hosp Univ Joao de Barros Barreto   (Brazil)

^e INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ANAPC1; CDKN2A; DNA methylation; Gastric cancer; TP53

Indexed keywords

ANAPHASE PROMOTING COMPLEX; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; BRAZIL; CANCER CLASSIFICATION; CANCER STAGING; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; DNA SEQUENCE; FEMALE; GASTRECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; STORAGE TEMPERATURE; UNIVERSITY HOSPITAL;

ADENOCARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; GENES, P16; GENES, P53; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 54749138808     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008000600017     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. INCA. Estimativa 2006: Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2005.
3. Pereira LP, Waisberg J, Andre EA, Zanoto A, Mendes Junior JP, Soares HP. Detection of Helicobacter pylori in gastric cancer. Arq Gastroenterol 2001; 38: 240-246.
4. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 6-21.
5. Lima EM, Rissino JD, Harada ML, Assumpcao PP, Demachki S, Guimaraes AC, et al. Conventional cytogenetic characterization of a new cell line, ACP01, established from a primary human gastric tumor. Braz J Med Biol Res 2004; 37: 1831-1838.
6. Atkin NB. Chromosomal doubling: the significance of polyploidization in the development of human tumors: possibly relevant findings on a lymphoma. Cancer Genet Cytogenet 2000; 116: 81-83.
7. Sugai T, Habano W, Jiao YF, Suzuki M, Takagane A, Nakamura S. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers. Oncology 2005; 68: 548-557.
8. Jorgensen PM, Graslund S, Betz R, Stahl S, Larsson C, Hoog C. Characterisation of the human APC1, the largest subunit of the anaphase-promoting complex. Gene 2001; 262: 51-59.
9. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-1677.
10. Ding Y, Le XP, Zhang QX, Du P. Methylation and mutation analysis of p16 gene in gastric cancer. World J Gastroenterol 2003; 9: 423-426.
11. Tang S, Luo H, Yu J, Yang D, Shu J. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis. Chin Med J 2003; 116: 1083-1087.
12. Fei P, El-Deiry WS. P53 and radiation responses. Oncogene 2003; 22: 5774-5783.
13. Hurt EM, Thomas SB, Peng B, Farrar WL. Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator. Cancer Biol Ther 2006; 5: 1154-1160.
14. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
15. Sobin LH, Wittekind C. TNM classification of malignant tumors. 6th edn. New York: Wiley-Liss; 2002.
16. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93: 9821-9826.
17. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-1431.
18. Hermann A, Gowher H, Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004; 61: 2571-2587.
19. Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, et al. Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer 2006; 106: 1250-1259.
20. An C, Choi IS, Yao JC, Worah S, Xie K, Mansfield PF, et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 2005; 11: 656-663.
21. Roa JC, Anabalon L, Roa I, Tapia O, Melo A, Villaseca M, et al. Promoter methylation profile in gastric cancer. Rev Med Chil 2005; 133: 874-880.
22. Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K, et al. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 2003; 94: 901-905.
23. Lee JH, Park SJ, Abraham SC, Seo JS, Nam JH, Choi C, et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 2004; 23: 4646-4654.
24. Tahara T, Arisawa T, Shibata T, Wang FY, Nakamura M, Sakata M, et al. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestion 2007; 75: 54-61.
25. Agirre X, Novo FJ, Calasanz MJ, Larrayoz MJ, Lahortiga I, Valganon M, et al. TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia. Mol Carcinog 2003; 38: 201-208.
26. Gonzalez-Gomez P, Bello MJ, Alonso ME, Aminoso C, Lopez-Marin I, De Campos JM, et al. Promoter methylation status of multiple genes in brain metastases of solid tumors. Int J Mol Med 2004; 13: 93-98.
27. Amatya VJ, Naumann U, Weller M, Ohgaki H. TP53 promoter methylation in human gliomas. Acta Neuropathol 2005; 110: 178-184.